MedLea

Curated by Signal

AI-based cardiorespiratory disease diagnosis tool for healthcare providers

Overview

AI-based cardiorespiratory disease diagnosis tool for healthcare providers. The company has developed software like WeResp, HemoTac, DigiScan, and AInspector that assists with decision support and disease analysis. It has features for patient management, telemonitoring drug decision managing, workflow management, and more.

Key facts

Founded: 2019
Headquarters: Rome, Italy
Stage: Sign up to view
Industry: Health Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Doctorsa
Online healthcare platform that connects international patients with certified healthcare professionals
Health TechnologyRome, Italy
Mediciva Online
E commerce platform specializing in the sale of medical devices, equipment, and supplies
Health TechnologyGalliate, Italy
Sicuro
Mobile-based application for monitoring medication adherence
Health TechnologyTrento, Italy

About MedLea

What does MedLea do?

AI-based cardiorespiratory disease diagnosis tool for healthcare providers.

Where is MedLea headquartered?

MedLea is headquartered in Rome, Italy.

When was MedLea founded?

MedLea was founded in 2019.

Which sector is MedLea in?

MedLea operates in Health Technology.

Who are MedLea's competitors?

Companies similar to MedLea include Doctorsa, Mediciva Online, and Sicuro.